EW

NYSEEdwards Lifesciences Corp
Calm Tide · 32Squeeze · Idle 16Neutral0 buys · -$287KSocial · Quiet 0
$86.18
$-0.54 (-0.62%)
15-min delayed · Sep 9, 10:57 PMReal-time

Score summary

Buy
Analyst Ratings
20Ratings
15 Buy5 Hold0 Sell
Tide Score
32
Calm Tide · stable · Bottom 10% of universe (3998)
Outlook63High Tide · stable · Top 23% of universe (3999)
Squeeze Score
16
Idle ·
  • Days to cover3.14
  • Short interest2.08% of float
  • Borrow rate40.07%
  • Short interest trend+0.03% (30d)
Trend
Neutral
No clear trend (signals split)
Recent Smart Money
0 buys
Quiet · -$287k · 14d · 5 super investors

Key statistics

Market Cap
$51.82B
52-week range
$72.65 – $95.18
19% from low
Day range
$86 – $87
Open $86.27
Volume
2.7M
vs 3.3M avg · 83%
P/E (TTM)
53.5
Fwd 26.6
Earnings
Oct 29
49d · est $0.74

Country ranks

US RankCountry rank populator pending
BW universe: US & CA common stocks only · ETFs and mutual funds excluded · Methodology →

Price chart with forecast cone and smart-money events

Wall Street Analyst Consensus

Wall Street Analyst Consensus
Aggregate of 20 third-party analyst opinions — not Quantellect advice.
12-mo median price target
$104
20 Wall St 12-month targets
High
$110
Average
$102
Low
$85
$76$85$94$102$111HIGH$110MEDIAN$104LOW$85Mar ’26NOW12-mo target
Recent price history, then Wall-Street analysts’ 12-month price targets (high / median / low) shown forward to the 12-month target levels. Targets are third-party analysts’ estimates of future performance — not guarantees, and not Quantellect recommendations. Past results do not guarantee future returns.
Per-analyst ratings are not yet available for this ticker.
Aggregate of third-party analysts’ published opinions, shown for information only — not Quantellect advice. The 69/100 Analyst Score (Buy) is Quantellect’ documented weighting of the rating distribution on the same 0–100 scale as the Tide / Squeeze / Trend / Money scores; the verdict label is derived from that score. Past results do not guarantee future returns. Source: aes.

Why Tide score breakdown

Smart-money feed

Social pulse

Smart-money modules

Catalysts ahead

Catalysts aheadEarnings Oct 29 (post-market, est EPS $0.74) · Annual shareholder meeting Jun 17 · Russell 1000 rebalance Jul 22 · DOJ CUDA hearing window Q3

Drill deeper

Not investment advice. Past results do not guarantee future returns. Scores, narratives, and historical-cohort statistics on this page are generated by Quantellect algorithms from public filings, market data, and AI synthesis, and describe the historical performance of structurally similar setups in our universe; failures are included. Data may be 15-minute delayed, contain errors, or be revised. Always do your own research and consult a licensed financial advisor before making investment decisions.